NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First in Human Ablations Completed with OneRF™ Ablation System
25 juin 2024 09h00 HE | NeuroOne Medical Technologies Corp
Five ablations performed successfully in one patient Procedure performed at patient’s bedside saving time and cost associated with the operating room EDEN PRAIRIE, Minn., June 25, 2024 (GLOBE...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation
20 juin 2024 09h30 HE | NeuroOne Medical Technologies Corp
ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF™ Ablation System for broader adoption and...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Reports Second Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
14 mai 2024 16h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 14, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Report Second Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on May 14
10 mai 2024 14h43 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Bloomberg Technology
10 avr. 2024 09h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 10, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Announces First Implant of OneRF™ Ablation Electrodes
09 avr. 2024 09h05 HE | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control EDEN PRAIRIE,...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® CEO Dave Rosa Featured on Fox Business Network’s Varney & Co.
04 avr. 2024 09h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., April 04, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) (“NeuroOne” or the “Company”), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® Initiates Limited Commercial Launch of OneRF™ Ablation System
26 mars 2024 09h00 HE | NeuroOne Medical Technologies Corp
First to market FDA-cleared thin-film, sEEG-guided RF system capable of both recording electrical activity and ablating nervous tissue with the added benefit of temperature control Limited...
NO16 NEUROONE LOGO_RGB.png
NeuroOne® to Participate in the 36th Annual Roth Conference
08 mars 2024 12h00 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., March 08, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...
NO16 NEUROONE LOGO_RGB.png
NeuroOne Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23 févr. 2024 17h10 HE | NeuroOne Medical Technologies Corp
EDEN PRAIRIE, Minn., Feb. 23, 2024 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (NASDAQ: NMTC) ("NeuroOne" or the "Company"), a medical technology company focused on improving...